Order Article Reprints

Dattilo G, Laterra G, Licordari R, Parisi F, Pistelli L, Colarusso L, Zappia L, Vaccaro V, Demurtas E, Allegra M, et al. The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population. Journal of Clinical Medicine. 2023; 12(19):6247. https://doi.org/10.3390/jcm12196247

Dattilo, Giuseppe, Giulia Laterra, Roberto Licordari, Francesca Parisi, Lorenzo Pistelli, Luigi Colarusso, Luca Zappia, Vittoria Vaccaro, Elisabetta Demurtas, Marta Allegra, and et al. 2023. "The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population" Journal of Clinical Medicine 12, no. 19: 6247. https://doi.org/10.3390/jcm12196247

Dattilo, G., Laterra, G., Licordari, R., Parisi, F., Pistelli, L., Colarusso, L., Zappia, L., Vaccaro, V., Demurtas, E., Allegra, M., Crea, P., Di Bella, G., Signorelli, S. S., Aspromonte, N., Imbalzano, E., & Correale, M. (2023). The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population. Journal of Clinical Medicine, 12(19), 6247. https://doi.org/10.3390/jcm12196247